Morningstar

Oncology Pharma Inc ONPH

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Benzinga.com

Oncology Pharma (OTC:ONPH) Stock, Short Interest Report

Short interest in Oncology Pharma Inc (OTC:ONPH) decreased during the last reporting period, falling from 13.45K to 13.45K. This put -% of the company's publicly available shares short. Short interest ...
Nasdaq

Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System

SAN FRANCISCO, CA / ACCESSWIRE / July 12, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") is furthering progress in discussions with investors and developing the ...
ETF Daily News

Head-To-Head Contrast: Confluent (NASDAQ:CFLT) vs. Oncology Pharma (OTCMKTS:ONPH)

78.1% of Confluent shares are owned by institutional investors. 18.0% of Oncology Pharma shares are owned by insiders. Comparatively, 13.8% of Confluent shares are owned by insiders. Strong ...
Nasdaq

Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next ...

SAN FRANCISCO, CA / ACCESSWIRE / June 8, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") is pleased that the initial feasibility stage is complete and results have ...
Barron's

Oncology Pharma Inc.

Oncology Pharma, Inc. engages in the development, manufacture and commercialization of therapeutics. The company was founded by Marcel van Heesewijk on March 26, 1993 and is headquartered in San ...